Undifferentiated Spondyloarthritis

Ankylosing Spondylitis and the Spondyloarthropathies

Volumn , Issue , 2006, Pages 75-93

  Zeidler, Henning ^a   Brandt, Jan ^b   Schnarr, Sebastian ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b RHEUMAZENTRUM RUHRGEBIET   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 66049136067     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-03104-2.50011-9     Document Type: Chapter

References (146)

1. Zeidler H, Mau W, Khan MA Undifferentiated spondyloarthropathies. Rheum Dis Clin North Am. 1992, 18:187-202.
2. Schumacher HR, Bardin T. The spondylarthropathies: classification and diagnosis Do we need new terminologies?. Balliëres Clin Rheumatol. 1998, 12:551-565.
3. Berthelot JM, Klarlund M, McGonagle D, et al. Lessons from an international survey of paper cases of 10 real patients from an early arthritis clinic. CRI (Club Rhumatismes et Inflammation) Group. J Rheumatol. 2001, 28:975-981.
4. Berthelot JM, Bernelot-Moens HJ, Klarlund M, et al. Differences in understanding and application of 1987 ACR criteria for rheumatoid arthritis and 1991 ESSG criteria for spondylarthropathy A pilot survey. Clin Exp Rheumatol. 2002, 20:145-150.
5. Berthelot JM, Saraux A, Le HenaffC, et al. Confidence in the diagnosis of early spondylarthropathy: a prospective follow-up of 270 early arthritis patients. Clin Exp Rheumatol. 2002, 20:319-326.
6. Burns TM, Calin A. Undifferentiated spondylarthropathy. Spondylarthropathies 1984, 253-264. Grune & Stratton, Orlando, FL. A. Calin (Ed.).
7. Khan MA, van der Linden SM Undifferentiated spondyloarthropathies. Ankylosing Spondylitis and Related Spondyloarthropathies 1990, 657-664. Hanley & Belfus, Philadelphia, Pa. M.A. Khan (Ed.).
8. Burns T, Marder A, Becks E, et al. Undifferentiated spondylarthritis: a nosological missing link?. Arthritis Rheum 1982, 25(suppl):142.
9. Nasrallah NS, Masi AT, Chandler RW, Feigenbaum SL, Kaplan SB HLA-B27 antigen and rheumatoid factor negative (seronegative) peripheral arthritis. Studies in younger patients with early diagnosed arthritis. Am J Med. 1977, 63:379-386.
10. Genth E, Peuckert H, Brude E, Hehl M, Hartl W. HLA-B27 positive oligoarthritis. Z Rheumatol. 1978, 37:313-328.
11. Schattenkirchner M, Krüger K. Natural course and prognosis of HLA-B27-positive oligoarthritis. Clin Rheumatol 1987, 6(suppl 2):83-86.
12. Prakash S, Mehra NK, Bhargva S, Malaviya AN HLA-B27 related 'unclassifiable' seronegative spondyloarthropathies. Ann Rheum Dis. 1983, 42:640-643.
13. Bitter T, Jeannet M, de Haller E, Lejeune M. Persistent yet reversible asymmetric pauciarthritis (PRAP): a B27-associated cluster. Ann Rheum Dis 1979, 38(suppl):84-91.
14. Eastmond CJ, Rajah SM, Tovey D, Wright V. Seronegative pauciarticular arthritis and HLA-B27. Ann Rheum Dis. 1980, 39:231-234.
15. Rosenberg AM, Petty RE A syndrome of seronegative enthesopathy and arthropathy in children. Arthritis Rheum. 1982, 25:1041-1047.
16. Dubost JJ, Sauvezie B. Late onset peripheral spondyloarthropathy. J Rheumatol. 1989, 16:1214-1217.
17. Thomson GTD, Inman RD Diagnostic conundra in the spondyloarthropathies: towards a base for revised nosology. J Rheumatol. 1990, 17:426-429.
18. Khan MA, van der Linden SM A wider spectrum of spondyloarthropathies. Semin Arthritis Rheum. 1990, 20:107-113.
19. Khan MA, van der Linden SM Ankylosing spondylitis and other spondyloarthropathies. Rheum Dis Clin North Am. 1990, 16:551-579.
20. Zeidler H. Undifferentiated arthritis and spondylarthropathy as a major problem of diagnosis and classification. Scand J Rheumatol 1987, 65(suppl):54-62.
21. Zeidler H, Werdier D, Klauder A, et al. Undifferentiated arthritis and spondylarthropathy as a challenge for prospective studies. Clin Rheumatol 1987, 6(suppl):112-120.
22. Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991, 34:1218-1227.
23. Francois RJ, Eulderink F, Bywaters EG Commented glossary for rheumatic spinal diseases, based on pathology. Ann Rheum Dis. 1995, 54:615-625.
24. Amor B, Dougados M, Mijiyawa M. Criteria of the classification of spondylarthropathies. Rev Rhum Mal Osteoartic. 1990, 57:85-89.
25. Boyer GS, Lanier AP, Templin DW Prevalence rates of spondyloarthropathies, rheumatoid arthritis, and other rheumatic disorders in an Alaskan Inupiat Eskimo population. J Rheumatol. 1988, 15:678-683.
26. Boyer GS, Templin DW, Cornoni-Huntley JC, et al. Prevalence of spondyloarthropathies in Alaskan Eskimos. J Rheumatol. 1994, 21:2292-2297.
27. Braun J, Bollow M, Remlinger G, et al. Prevalence of spondyl-arthropathies in HLA B27-positive and -negative blood donors. Arthritis Rheum. 1998, 41:58-67.
28. Brandt J, Bollow M, Häberle J, et al. Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging: many, but not all patients with sacroiliitis have spondyloarthropathy. Rheumatology (Oxford). 1999, 38:831-836.
29. Mau W, Zeidler H, Mau R, et al. Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup. J Rheumatol. 1988, 15:1109-1114.
30. Baddoura R, Awada H, Okais J, Habis T, Attoui S, Abi Saab M. Validation of the European Spondylarthropathy Study Group and B Amor criteria for spondylarthropathies in Lebanon. Rev Rhum Engl Ed. 1997, 64:459-464.
31. Hukuda S, Minami M, Saito T, et al. Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society. J Rheumatol. 2001, 28:554-559.
32. Rudwaleit M, Listing J, Marker-Hermann E, et al. Clinical manifestations at disease onset and during the disease course in early spondyloarthritis. Arthritis Rheum 2004, 50(suppl):S617.
33. Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. How to diagnose axial spondyloarthritis early. Ann Rheum Dis. 2004, 63:535-543.
34. Mader R. Atypical clinical presentation of ankylosing spondylitis. Semin Arthritis Rheum. 1999, 29:191-196.
35. Ferdoutsis M, Bouros D, Meletis G, Patsourakis G, Siafakas NM Diffuse interstitial lung disease as an early manifestation of ankylosing spondylitis. Respiration. 1995, 62:286-289.
36. Arnett FC Incomplete Reiter's syndrome: clinical comparisons with classical triad. Ann Rheum Dis 1979, 38(suppl 1):73-78.
37. Zeidler H, Wagener P, Eckert G, et al. HLA-B27 in possible ankylosing spondylitis with peripheral arthritis. Rheumatol Int. 1982, 2:35-40.
38. Kaarela K, Titinen S, Luukkainen R. Long-term prognosis of monoarthritis, a follow-up study. Scand J Rheumatol. 1983, 12:374-376.
39. Nissilä M, Isomäki H, Kaarela K, Kiviniemi P, Martio J, Sarna S. Prognosis of inflammatory joint disease: a three-year follow-up study. Scand J Rheumatol. 1983, 12:33-38.
40. Blocka KLN, Sibley JT Undiagnosed chronic monoarthritis: clinical and evolutionary profile. Arthritis Rheum. 1987, 30:1357-1361.
41. Sambrook P, McGuigan L, Champion D, Edmonds J, Fleming A, Portek I. Clinical features and follow-up study of HLA-B27 positive patients presenting with peripheral arthritis. J Rheumatol. 1985, 12:526-528.
42. Hülsemann JL, Zeidler H. Undifferentiated arthritis in an early synovitis out-patient clinic. Clin Exp Rheumatol. 1995, 13:37-43.
43. Kvien TK, Glennas A, Melby K. Prediction of diagnosis in acute and subacute oligoarthritis of unknown origin. Br J Rheumatol. 1996, 35:359-363.
44. de Saint Pierre V, Saraux A, Lamour A, et al. Spondylarthropathy with distal joint involvement. Scand J Rheumatol. 1996, 25:331-333.
45. Saraux A, Guedes C, Allain J, et al. Valeur diagnostique du phénotype HLA dans les rhumatismes inflammatoires. Press Med. 1997, 26:1040-1044.
46. El-Gabalawy HS, Goldbach-Mansky R, Smith D, et al. Association of HLA alleles and clinical features in patients with synovitis of recent onset. Arthritis Rheum. 1999, 42:1696-1705.
47. Inaoui R, Bertin P, Preux PM, Treves R. Outcome of patients with undifferentiated chronic monoarthritis: retrospective study of 46 cases. Joint Bone Spine. 2004, 71:209-213.
48. Olivieri I, Barozzi L, Padula A. Enthesiopathy: clinical manifestations, imaging and treatment. BailliËres Clin Rheumatol. 1998, 12:665-681.
49. Gerster JC Plantar fasciitis and Achilles tendinitis among 150 cases of seronegative spondarthritis. Rheumatol Rehabil. 1980, 19:218-222.
50. Olivieri I, Foto M, Ruju GP, Gemignani G, Giustarini S, Pasero G. Low frequency of axial involvement in Caucasian pediatric patients with seronegative enthesopathy and arthropathy syndrome after 5 years of disease. J Rheumatol. 1992, 19:469-475.
51. Olivieri I, Padula A, Pierro A, Favaro L, Oranges GS, Ferri S. Late onset undifferentiated seronegative spondyloarthropathy. J Rheumatol. 1995, 22:899-903.
52. Rezaian MM, Brent LH Undifferentiated spondyloarthropathy: three year follow-up study of 476 patients. Arthritis Rheum 1997, 40(suppl):S227.
53. Olivieri I, Gemignani G, Gherardi S, Grassi L, Ciompi ML Isolated HLA-B27 Achilles tendinitis. Ann Rheum Dis. 1987, 46:626-627.
54. Olivieri I, Pasero G. Longstanding isolated juvenile onset HLA-B27 associated peripheral enthesitis. J Rheumatol. 1987, 46:164-165.
55. Malmivaara A, Viikari-Juntura E, Huuskonen M, et al. Rheumatoid factor and HLA antigens in wrist tenosynovitis and humeral epicondylitis. Scand J Rheumatol. 1995, 24:154-156.
56. Godfrin B, Zabraniecki L, Lamboley V, Bertrand-Latour F, Sans N, Fournie B. Spondyloarthropathy with entheseal pain A prospective study in 33 patients. Joint Bone Spine. 2004, 71:557-562.
57. Pato E, Banares A, Jover JA, et al. Undiagnosed spondyloarthropathy in patients presenting with anterior uveitis. J Rheumatol. 2000, 27:2198-2202.
58. Tay-Kearney ML, Schwam BL, Lowder C, et al. Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol. 1996, 121:47-56.
59. Monnet D, Breban M, Hudry C, Dougados M, Brezin AP Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis. Ophthalmology. 2004, 111:802-809.
60. Linder R, Hoffmann A, Brunner R. Prevalence of the spondyloarthritides in patients with uveitis. J Rheumatol. 2004, 31:2226-2229.
61. Bergfeldt L. HLA-B27-associated cardiac disease. Ann Intern Med. 1997, 127:621-629.
62. Bergfeldt L. HLA-B27-associated rheumatic diseases with severe cardiac bradyarrhythmias. Clinical features and prevalence in 223 men with permanent pacemakers. Am J Med. 1983, 75:210-215.
63. Bergfeldt L, Möller E. Complete heart block---another HLA-B27 associated disease manifestation. Tissue Antigens. 1983, 21:385-390.
64. Bergfeldt L, Edhag O, Rajs J. HLA-B27-associated heart disease. Clinicopathologic study of three cases. Am J Med. 1984, 77:961-967.
65. Qaiyumi S, Hassan ZU, Toone E. Seronegative spondyloarthropathies in lone aortic insufficiency. Arch Intern Med. 1985, 145:822-824.
66. Bergfeldt L, Insulander P, Lindblom D, Moller E, Edhag O. HLA-B27: an important genetic risk factor for lone aortic regurgitation and severe conduction system abnormalities. Am J Med. 1988, 85:12-18.
67. Sahi SP, Winfield CR Third-degree heart block developing in an HLA-B27-positive individual with a family history of ankylosing spondylitis. Br J Clin Pract. 1990, 44:794-795.
68. Peeters AJ, ten Wolde S, Sedney MI, de Vries RR, Dijkmans BA Heart conduction disturbance: an HLA-B27 associated disease. Ann Rheum Dis. 1991, 50:348-350.
69. Bergfeldt L, Möller E. Pacemaker treated women with heart block have no increase in the frequency of HLA-B27 and associated rheumatic disorders in contrast to men---a sex-linked difference in disease susceptibility. J Rheumatol. 1986, 13:941-943.
70. Olivieri I. Undifferentiated seronegative spondyloarthropathy in females. Br J Rheumatol. 1996, 35:395-398.
71. Malaviya AN, Mehra NK Spondyloarthropathies in India. Ankylosing Spondylitis and Related Spondyloarthropathies. Spine: State of the Art Reviews 1990, 679-684. Hanley & Belfus, Philadelphia, Pa. M.A. Khan (Ed.).
72. Uppal SS, Pande I, Singh G, et al. Profile of HLA-B27 related 'unclassifiable' spondyloarthropathy in females and its comparison with the profile in males. Br J Rheumatol. 1995, 34:137-140.
73. Boyer GS, Templin DW, Bowler A, et al. Spondyloarthropathy in the community: differences in severity and disease expression in Alaskan Eskimo men and women. J Rheumatol. 2000, 27:170-176.
74. Prieur A-M Spondyloarthropathies in childhood. Balliéres Clin Rheumatol. 1998, 12:287-307.
75. Olivieri I, Salvarani C, Cantini F, Ciancio G, Padula A. Ankylosing spondylitis and undifferentiated spondyloarthropathies: a clinical review and description of a disease subset with older age at onset. Curr Opin Rheumatol. 2001, 13:280-284.
76. Dubost JJ, Ristori JM, Zmantar C, Sauvezie B. Rhumatismes séronégatifs a début tardif: fréquence et atypies des spondylarthropathies. Rev Rhum Mal Osteoartic. 1991, 58:577-584.
77. Caplanne D, Tubach F, Le Parc JM Late onset spondylarthropathy: clinical and biologic comparison with early onset patients. Ann Rheum Dis. 1997, 56:176-179.
78. Olivieri I, Oranges GS, Sconosciuto F, Padula A, Ruju GP, Pasero G. Late onset peripheral seronegative spondyloarthropathy: report of two additional cases. J Rheumatol. 1993, 20:390-393.
79. Khan MA, van der Linden SM, Kushner I, Valkenburg HA, Cats A. Spondylitic disease without radiologic evidence of sacroiliitis in relatives of HLA-B27 positive ankylosing spondylitis patients. Arthritis Rheum. 1985, 28:40-43.
80. Mielants H, Veys EM, Cuvelier C, De Vos M. Subclinical involvement of the gut in undifferentiated spondylarthropathies. Clin Exp Rheumatol. 1989, 7:499-504.
81. Altomonte L, Zoli A, Veneziani A, et al. Clinically silent inflammatory gut lesions in undifferentiated spondyloarthropathies. Clin Rheumatol. 1994, 13:565-570.
82. Olivieri I, Costa AM, Cantini F, Niccoli L, Marini R, Ferri S. Pyoderma gangrenosum in association with undifferentiated seronegative spondylarthropathy. Arthritis Rheum. 1996, 39:1062-1065.
83. Lau CS, Burgos-Vargas R, Louthrenoo W, Mok MY, Wordsworth P, Zeng QY Features of spondyloarthritis around the world. Rheum Dis Clin North Am. 1998, 24:753-770.
84. Rynes RI, Volastro PS, Bartholomew LE Exacerbation of B27 positive spondyloarthropathy by enteric infections. J Rheumatol. 1984, 11:96-97.
85. Golding DN, Robertson MH Reactive arthritis due to Salmonella schwarzengrund in a patient with asymptomatic spondylitis. Br J Rheumatol. 1985, 24:194-196.
86. Paul IR, Mitchell ES, Bell AL Salmonella reactive arthritis in established ankylosing spondylitis. Ulster Med J 1988, 57:215-217.
87. Leirisalo-Repo M, Suoranta H. Ten-year follow-up study of patients with Yersinia arthritis. Arthritis Rheum. 1988, 31:533-537.
88. Herrero-Beaumont G, Elswood J, Will R, Armas JB, Calin A. Postsalmonella reactive phenomena in 2 patients with ankylos-ing spondylitis: no modification of the underlying disease. J Rheumatol. 1990, 17:250-251.
89. Gran JT, Paulsen AQ, Gaskjenn H, Schulz T. Reactive arthritis of the cervical spine due to Yersinia enterocolitica in a patient with pre-existing ankylosing spondylitis. Scand J Rheumatol. 1992, 21:95-96.
90. Yli-Kerttula T, Tertti R, Toivanen A. Ten-year follow-up study of patients from a Yersinia pseudotuberculosis III outbreak. Clin Exp Rheumatol. 1995, 13:333-337.
91. Speed CA, Haslock I. Coincident seronegative spondarthritis: a case report. Clin Rheumatol. 1996, 15:301-302.
92. Aggarwal A, Misra R, Chandrasekhar S, Prasad KN, Dayal R, Ayyagari A. Is undifferentiated seronegative spondyloarthropathy a forme fruste of reactive arthritis?. Br J Rheumatol 1997, 36:1001-1004.
93. Bas S, Griffais R, Kvien TK, Glennas A, Melby K, Vischer TL Amplification of plasmid and chromosomal chlamydial DNA on synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthritis. Arthritis Rheum. 1995, 38:1005-1013.
94. Erlacher L, Wintersberger W, Menschik M, et al. Reactive arthritis: urogenital swab culture is the only useful method for the detection of the arthritogenic infection in extra-articularly asymptomatic patients with undifferentiated oligoarthritis. Br J Rheumatol. 1995, 34:838-842.
95. Sieper J, Braun J, Brandt J, et al. Pathogenetic role of Chlamydia, Yersinia and Borrelia in undifferentiated oligoarthritis. J Rheumatol. 1992, 19:1236-1242.
96. Schnarr S, Putschky N, Jendro MC, et al. Chlamydia and Borrelia DNA in synovial fluid of patients with early undifferentiated oligoarthritis: results of a prospective study. Arthritis Rheum 2001, 44:2679-2685.
97. Sinha R, Aggarwal A, Prasad K, Misra R. Sporadic enteric reactive arthritis and undifferentiated spondyloarthropathy: evidence for involvement of Salmonella typhimurium. J Rheumatol. 2003, 30:105-113.
98. Martinez A, Pacheco-Tena C, Vazquez-Mellado J, Burgos-Vargas R. Relationship between disease activity and infection in patients with spondyloarthropathies. Ann Rheum Dis. 2004, 63:1338-1340.
99. Schwartzenberg JM, Smith DD, Lindsley HB Bacillus CalmetteGuérin associated arthropathy mimicking undifferentiated spondyloarthropathy. J Rheumatol. 1999, 26:933-935.
100. Brandt J, Buss B, Sieper J, et al. Treatment with sulfasalazine vs azathioprine of ankylosing spondylitis patients with a disease duration 10 years. Arthritis Rheum 2000, suppl 43:S218.
101. Braun J, Alten R, Burmester G, et al. Efficacy of sulfasalazine in undifferentiated spondyloarthritis and early ankylosing spondylitis---a multicenter randomized controlled trial. Arthritis Rheum 2004, 50:4100. (late-breaking abstract).
102. Van den Bosch F, Kruithof E, Baeten D, De Keyser R, Mielants H, Veys EM Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study. Ann Rheum Dis. 2000, 59:428-433.
103. Brandt J, Haibel H, Sieper J, Braun J. Successful treatment of patients with severe undifferentiated spondyloarthropathy with the anti-TNFα antibody infliximab. J Rheumatol. 2002, 29:118-122.
104. Collantes-Estevez E, Munoz-Villanueva MC, Canete-Crespillo JD, et al. Infliximab in refractory spondyloarthropathies: a multicentre 38 week open study. Ann Rheum Dis. 2003, 62:1239-1240.
105. Marzo-Ortega H, McGonagle D, O'Connor P, Emery P. Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis. Ann Rheum Dis. 2003, 62:74-76.
106. Brandt J, Khariouzov A, Listing J, et al. Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept. J Rheumatol. 2004, 31:531-538.
107. Garrett S, Jenkinson TR, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis. The Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994, 21:2286-2291.
108. Calin A, Nakache J-P, Gueguen A, Zeidler H, Mielants H, Dougados M. Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?. Rheumatology (Oxford) 1999, 38:878-882.
109. Mander M, Simpson JM, McLellan A, Walker D, Goodacre JA, Dick WC Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis. 1987, 46:197-202.
110. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis. 2003, 62:127-132.
111. Braun J, Brandt J, Listing J, et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet. 2002, 359:1187-1193.
112. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis. The Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994, 21:2286-2291.
113. Masson G, Thomas P, Bontoux D, Alcalay M. Influence of trauma on initiation of Reiter's syndrome and ankylosing spondylitis. Ann Rheum Dis. 1985, 44:860-861.
114. SandorfiN, Freundlich B. Psoriatic and seronegative inflammatory arthropathy associated with a traumatic onset: 4 cases and a review of the literature. J Rheumatol. 1997, 24:187-192.
115. Sany J, Rosenberg F, Panis G, Serre H. Unclassified HLA-B27 inflammatory rheumatic diseases: follow-up of 23 patients. Arthritis Rheum. 1980, 23:258-259.
116. Zeidler H, Mau R, Mau W, Freyschmidt J, Majewski A, Deicher H. Evaluation of early diagnostic criteria including HLA-B27 for ankylosing spondylitis in a follow-up study. Z Rheumatol. 1985, 44:249-253.
117. Wagener P, Mau W, Zeidler H, Eckert G, Robin-Winn M, Deicher H. HLA-B27 and clinical aspects of ankylosing spondylitis: results of prospective studies. Immunol Rev. 1985, 86:93-100.
118. Mau W, Zeidler H, Mau R, Majewski A, Freyschmidt J, Deicher H. Outcome of possible ankylosing spondylitis in a 10 years' follow-up study. Clin Rheumatol 1987, 6(suppl 2):60-66.
119. Mau W, Zeidler H, Mau R, et al. Evaluation of early diagnostic criteria for ankylosing spondylitis in a 10-year follow-up. Z Rheumatol. 1990, 49:82-87.
120. Sampaio-Barros PD, Bertolo MB, Kraemer MHS, Marques-Neto JF, Samara AM Undifferentiated spondyloarthropathies: a 2-year follow-up study. Clin Rheumatol. 2001, 20:201-206.
121. Kumar A, Bansal M, Srivastava DN, et al. Long-term outcome of undifferentiated spondylarthropathy. Rheumatol Int. 2001, 20:221-224.
122. Jänti JK, Kaarela K, Lehtinen KES Seronegative oligoarthritis: a 23-year follow-up study. Clin Rheumatol. 2002, 21:353-356.
123. Blackburn WD, Alacrcon GS, Ball GV Evaluation of patients with back pain of suspected inflammatory nature. Am J Med. 1988, 85:766-770.
124. Zink A, Braun J, Listing J, Wollenhaupt J. Disability and handicap in rheumatoid arthritis and ankylosing spondylitis---results from the German rheumatological database. German Collaborative Arthritis Centers. J Rheumatol. 2000, 27:613-622.
125. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum. 1984, 27:361-368.
126. Braun J, Bollow M, Eggens U, Konig H, Distler A, Sieper J. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum. 1994, 37:1039-1045.
127. Braun J, Bollow M, Sieper J. Radiologic diagnosis and pathology of the spondyloarthropathies. Rheum Dis Clin North Am. 1998, 24:697-735.
128. Braun J, Bollow M, Seyrekbasan F, et al. Computed tomography guided corticosteroid injection of the sacroiliac joint in patients with spondyloarthropathy with sacroiliitis: clinical outcome and followup by dynamic magnetic resonance imaging. J Rheumatol. 1996, 23:659-664.
129. Braun J, Pham T, Sieper J, Davis J, van der Linden S, Dougados M, et al. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis. 2003, 62:817-824.
130. Dequeker J, Goddeeris T, Walravens M, De Roo M. Evaluation of sacro-iliitis: comparison of radiological and radionuclide techniques. Radiology. 1978, 128:687-689.
131. D'Agostino M, Said-Nahal R, Hacquard-Bouder C, Brasseur JL, Dougados M, Breban M. Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler. Arthritis Rheum. 2003, 48:523-533.
132. Biasi D, Carletto A, Caramaschi P, Pacor ML, Maleknia T, Bambara LM Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three year open study. Clin Rheumatol. 2000, 19:114-117.
133. Roychowdhury B, Bintley-Bagot S, Bulgen DY, Thompson RN, Tunn EJ, Moots RJ Is methotrexate effective in ankylosing spondylitis?. Rheumatology (Oxford) 2002, 41:1330-1332.
134. Altan L, Bingol U, Karakoc Y, Aydiner S, Yurkuran M, Yurkuran M. Clinical investigation of methotrexate in the treatment of ankylosing spondylitis. Scand J Rheumatol. 2001, 30:255-259.
135. Gonzalez-Lopez L, Garcia-Gonzalez A, Vazquez del Mercado M, Munoz-Valle JF, Gamez-Nava JI Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial. J. Rheumatol. 2004, 31:1568-1574.
136. Queiro R, De Dios JR Successful treatment with low-dose weekly methotrexate in a case of undifferentiated spondyloarthropathy coexisting with cutaneous polyarteritis nodosa. Clin Rheumatol. 2002, 21:304-305.
137. Braun J, Bollow M, Neure L, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum. 1995, 38:499-505.
138. Gorman JD, Sack KE, Davis JC Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α. N Engl J Med. 2002, 346:1349-1356.
139. Van den Bosch F, Kruithof E, Baeten D, et al. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathy. Arthritis Rheum. 2002, 46:755-765.
140. Kruithof E, Van den Bosch F, Baeten D, et al. Repeated infusions of infliximab, a chimeric anti-TNFα monoclonal antibody, in patients with active spondyloarthropathy: one year follow up. Ann Rheum Dis. 2002, 61:207-212.
141. Schnarr S, Hülsemann JL, Merkesdal S, et al. Anti-tumor necrosis factor-α therapy with the chimeric monoclonal antibody infliximab in severe undifferentiated spondyloarthropathy. Ann Rheum Dis 2004, 63(suppl 1):422.
142. Marzo-Ortega H, McGonagle D, O'Connor P, Emery P. Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study. Arthritis Rheum. 2001, 44:2112-2117.
143. Burgos-Vargas R, Vazquez-Mellado J, Pacheco-Tena C, Harnandez-Garduno A, Goycochea-Robles MV A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies. Ann Rheum Dis. 2002, 61:941-942.
144. Lehtinen A, Leirisalo-Repo M, Taavitsainen M. Persistence of enthesopathic changes in patients with spondylarthropathy during a 6-month follow-up. Clin Exp Rheumatol. 1995, 13:733-736.
145. Dougados M, van der Linden S, Leirisalo-Repo M, et al. Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum. 1995, 38:618-627.
146. Clegg DO, Reda DJ, Abdellatif M. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study. Arthritis Rheum. 1999, 42:2325-2329.